title: Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab.
authors.affiliation: University of Bari, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Anelli
authors.forename: Diletta Domenica
authors.initials: DD
authors.lastname: Torres
authors.forename: Carlo
authors.initials: C
authors.lastname: Manno
authors.forename: Crescenzio
authors.initials: C
authors.lastname: Scioscia
authors.forename: Florenzo
authors.initials: F
authors.lastname: Iannone
authors.forename: Michele
authors.initials: M
authors.lastname: Covelli
authors.forename: Francesco Paolo
authors.initials: FP
authors.lastname: Schena
authors.forename: Giovanni
authors.initials: G
authors.lastname: Lapadula
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000821:virology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000821:virology; D004279:DNA, Viral / Q000037:antagonists & inhibitors*; D005260:Female; D006515:Hepatitis B virus / Q000235:genetics* / Q000502:physiology; D006801:Humans; D000069285:Infliximab; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D007674:Kidney Diseases / Q000188:drug therapy* / Q000503:physiopathology / Q000821:virology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D004279:DNA, Viral; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab